This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Taleb, N. Articles by Nasrallah, M. Search for Related Content Social Bookmarking                         What's this?

Vascular complications of diabetes in Lebanon: Experience at the American University of Beirut

Internal Medicine, Endocrinology American University of Beirut Medical Centre

Haytham Salti

Ophthalmology, American University of Beirut Medical Centre

Mona Al-Mokaddam

Internal Medicine, Endocrinology American University of Beirut Medical Centre

Marie Merheb

Internal Medicine, Endocrinology American University of Beirut Medical Centre

Ibrahim Salti

Internal Medicine, Endocrinology American University of Beirut Medical Centre

Mona Nasrallah

Internal Medicine, Endocrinology American University of Beirut Medical Centre, Mn36{at}aub.edu.lb

Aim To examine the metabolic control and presence of

complications, among a cohort of diabetic patients in Lebanon. Method A total of 313 diabetic patients presenting for their usual care were screened in a cross-sectional manner for metabolic control and presence of complications at the American University of Beirut.

Results Only 235 subjects completed their data of whom 220 (93%) had type 2 diabetes with mean duration of disease of 8.2 (±6.6) years. Only 30% had haemoglobin A_1C < 7%, and 35.5% had low-density lipoprotein Cholesterol < 2.6 mmol/L. About 50.5% were obese, 34.9% current smokers, and 40.7% had blood pressure 140/90 mmHg. Microvascular complications were present as 46.3, 39.9 and 33% for albuminuria, neuropathy, 33% for albuminuria, neuropathy, and retinopathy, respectively. Macrovascular complications were as follows: 19.3, 18.3 and 4.1% for coronary artery disease, peripheral vascular disease and cerebrovascular disease, respectively.

Conclusions This study highlights the poor control and high prevalence of vascular complications among adult type 2 diabetic patients in Lebanon.

Key Words: diabetic complications • epidemiology • Lebanon • type 2 diabetes.

References

• Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the develop
• ing world a growing challenge. N Engl J Med 2007;356:213-16.[Free Full Text]
• Hirbli K., Jambeine M., Slim H. et al. Prevalence of diabetes in greater Beirut. Diabetes Care 2005;28:1262.[Free Full Text]
• WHO 2008, Prevalence of diabetes in the WHO Eastern Mediterranean Region. Available from: http://www.who.int/diabetes/facts/world_figures/en/index2.html
• ADA. Standards of medical care in diabetes. Diabetes Care 2007;30:S4-S41[Free Full Text]
• Akel M., Hamadeh G. Quality of diabetes care in university health center in Lebanon. Int J Qual Health Care 1999;11:517-21.[Abstract/Free Full Text]
• Major S., Salti I., Masri A. et al. Managing diabetes mellitus in a Lebanese Primary Care Center. Working towards change. Leb Med J 1998;46:182-7
• Salti I., Khogali M., Alam S. et al. Epidemiology of diabetes in relation to other cardiovascular risk factors in Lebanon. East Mediterr Health J 1997;3:462-71.
• Unnikrishnan R., Rema M., Pradeepa R. et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Epidemiology study. Diabetes Care 2007;30:2019-24.[Abstract/Free Full Text]
• Girach A., Manner D., Porta M. Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract 2006;11:1471-83.
• Al-Maskari F., El-Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol 2007;7:11.[CrossRef][Medline] [Order article via Infotrieve]
• Rema M., Premkumar S., Anitha B. et al. Prevalence of diabetic retinopathy in urban India: the chennai urban rural epidemiology study (CURES). Invest Ophthalmol Vis Sci 2005;46:2328-33.[Abstract/Free Full Text]
• Fleming B., Greenfield S., Engelgau M. et al. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 2001;24:1815-20.[Free Full Text]
• Saaddine J., Cadwell B., Gregg E. et al. Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-74.[Abstract/Free Full Text]
• Aace. DM Clinical Practice Guidelines Task Force: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus. Endocr Pract 2007;13:40-7.

The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 2, 80-83 (2008)
DOI: 10.1177/14746514080080020501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Taleb, N. Articles by Nasrallah, M. Search for Related Content Social Bookmarking                         What's this?